Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
161 hedge funds and large institutions have $1.32B invested in Spectrum Pharmaceuticals Inc in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 50 reducing their positions, and 20 closing their positions.
30% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 20
18% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 50
3% more funds holding
Funds holding: 157 → 161 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less capital invested
Capital invested by funds: $1.51B → $1.32B (-$190M)
41% less call options, than puts
Call options by funds: $8.28M | Put options by funds: $14M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
+$56.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$15.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.6M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$11.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$9.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$23.4M |
| 2 |
BlackRock
New York
|
-$18.3M |
| 3 |
D.E. Shaw & Co
New York
|
-$12.2M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$12.1M |
| 5 |
Renaissance Technologies
New York
|
-$11.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VIA
176
Vantage Investment Advisors
State College,
Pennsylvania
| – | -$4K | -200 | Closed |
|
|
II
177
Inspire Investing
Meridian,
Idaho
| – | -$2K | -93 | Closed |
|
178
AssetMark Inc
Concord,
California
| – | -$1K | -29 | Closed |
|
|
QCG
179
Quadrant Capital Group
Cincinnati,
Ohio
| – | +$832 | +42 | New |
|
SPPI Hedge Fund Activity: Q1 2018 in Review
161 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2018, worth a combined $1.32B — down 13% from $1.51B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new SPPI positions and 20 closed out — a net gain of 6 holders — while 59 added to existing stakes and 50 trimmed.
The largest buyer was Primecap Management, adding an estimated $56.5M. The largest seller was Consonance Capital Management, cutting an estimated $23.4M.
- 161 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2018, up from 157 in Q4 2017.
- Funds reported $1.32B of Spectrum Pharmaceuticals Inc stock for Q1 2018, down 13% quarter-over-quarter.
- 26 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2018 and 20 closed out, a net change of +6 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q1 2018 was Primecap Management, an estimated $56.5M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q1 2018 was Consonance Capital Management, an estimated $23.4M sold.
Based on aggregated 13F filings for Q1 2018.